• HOME
• ABOUT US
• INVESTOR CENTRE
  • Reports
  • Media
  • Powerpoint Summary
  • Photo Gallery
• Cancer Chemoprevention
  • Introduction to Breast Cancer and Chemoprevention
  • Research Team
• CORPORATE DIRECTORY
  • Directors
  • Corporate Information
• Global Market
  • Risk Reduction
  • Mammograms
• CONTACT US

Welcome

Beta Pharmaceutical Limited is a research-based biopharmaceutical company focused on the identification, development and commercialization of products and therapies targeting the chemoprevention and treatment of breast cancer.

The Company is working in collaboration with scientists at the College of Pharmacy, University of Louisiana at Monroe in southern USA ("ULM") to develop novel cancer chemopreventive agents using natural phytonutrients, called tocotrienols as treatments for breast cancers. Tocotrienols are found preferentially in palm oil and have been shown by previous scientific research to be potent anticancer agents able to turn on the death pathways for cancer cells and, at the same time, turns off the growth pathways.

Funded by Beta Pharmaceutical Limited, the applied research programme with ULM involving 4 laboratories and known as the Breast Cancer and Health Project has... Read More

Audio Interview

ULM President's Podium interview
Press play to listen
/investor/media/ULMPresidentsPodium.mp3

Media

4th December, 2009
The West Australian News Paper: Plans for anti-cancer pill in two years [PDF, 61KB]

18th November, 2009
Treatment unveiled: Cancer research at ULM nears fruition [PDF, 14KB]

29th January, 2009
ULM News Center Article: Company pledges nearly $400,000 in additional funding for ULM Cancer Project [PDF, 105KB]